A recent German AML Cooperative Group (AMLCG) publication reported on a study of paired specimens from 250 FLT3-ITD positive patients treated on AMLCG trials, for which both high-throughput amplicon sequencing (HTAS) and PCR-fragment analysis were performed [40]. This evidence concerns the gene FLT3 and acute myeloid leukemia.